Case-control study examining the association between hip fracture risk and statins therapy in old people

被引:10
作者
Cheng, Kao-Chi [1 ,2 ,3 ]
Liao, Kuan-Fu [4 ,5 ]
Lin, Cheng-Li [1 ,6 ]
Lin, Cheng-Chieh [1 ,2 ,7 ]
Lai, Shih-Wei [1 ,2 ]
机构
[1] China Med Univ Hosp, Coll Med, Taichung, Taiwan
[2] China Med Univ Hosp, Dept Family Med, 2 Yuh Der Rd, Taichung 404, Taiwan
[3] Providence Univ, Dept Food & Nutr, Taichung, Taiwan
[4] Taichung Tzu Chi Gen Hosp, Dept Internal Med, Div Hepatogastroenterol, Taichung, Taiwan
[5] Tzu Chi Univ, Coll Med, Hualien, Taiwan
[6] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan
[7] Asia Univ, Coll Hlth Sci, Dept Healthcare Adm, Taichung, Taiwan
关键词
case-control studies; elderly; hip fracture; osteoporosis; statins; BONE-MINERAL DENSITY; POPULATION-BASED COHORT; DIABETES-MELLITUS; SYNERGISTIC INTERACTION; IN-VITRO; CHOLESTEROL; POLYPHARMACY; PREVENTION; INHIBITOR; MECHANISM;
D O I
10.1097/MD.0000000000017476
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A population-based case-control study investigated possible association between statin use and risk of hip fracture among the elderly in Taiwan. The Taiwan National Health Insurance Program database was used to identify 7464 subjects aged 65 years or older with newly diagnosed hip fracture in 2000 to 2013. An additional 7464 subjects aged 65 years or older without hip fracture were randomly selected as the control group. Hip fracture cases and controls were matched for sex, age, comorbidities, and index year of hip fracture diagnosis. Statin use was defined as "current," "recent," or "past" if the patient's statin prescription was respectively filled <3, 3 to 6, or =6 months before the date of the hip fracture. The odds ratio (OR) and 95% confidence interval (CI) for hip fracture associated with statin use was estimated using the logistic regression model. The logistic regression analysis demonstrated that the odds of current statin use in cases with hip fracture were lower than the odds of current statin use in subjects without hip fracture (adjusted OR 0.73, 95% CI 0.65, 0.82). The odds of current statin use in cases with hip fracture were lower than the odds of current statin use in subjects without hip fracture in elderly people in Taiwan.
引用
收藏
页数:5
相关论文
共 38 条
[1]   MEVINOLIN - A HIGHLY POTENT COMPETITIVE INHIBITOR OF HYDROXYMETHYLGLUTARYL-COENZYME-A REDUCTASE AND A CHOLESTEROL-LOWERING AGENT [J].
ALBERTS, AW ;
CHEN, J ;
KURON, G ;
HUNT, V ;
HUFF, J ;
HOFFMAN, C ;
ROTHROCK, J ;
LOPEZ, M ;
JOSHUA, H ;
HARRIS, E ;
PATCHETT, A ;
MONAGHAN, R ;
CURRIE, S ;
STAPLEY, E ;
ALBERSSCHONBERG, G ;
HENSENS, O ;
HIRSHFIELD, J ;
HOOGSTEEN, K ;
LIESCH, J ;
SPRINGER, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (07) :3957-3961
[2]   The associations of subclinical atherosclerotic cardiovascular disease with hip fracture risk and bone mineral density in elderly adults [J].
Barzilay, J. I. ;
Buzkova, P. ;
Cauley, J. A. ;
Robbins, J. A. ;
Fink, H. A. ;
Mukamal, K. J. .
OSTEOPOROSIS INTERNATIONAL, 2018, 29 (10) :2219-2230
[3]   Association of Selective Serotonin Reuptake Inhibitor Use and Acute Angle-Closure Glaucoma [J].
Chen, Hsin-Yi ;
Lin, Cheng-Li ;
Lai, Shih-Wei ;
Kao, Chia-Hung .
JOURNAL OF CLINICAL PSYCHIATRY, 2016, 77 (06) :E692-E696
[4]   Risk of esophagus cancer in diabetes mellitus: a population-based case-control study in Taiwan [J].
Cheng, Kao-Chi ;
Chen, Yu-Lung ;
Lai, Shih-Wei ;
Tsai, Pang-Yao ;
Sung, Fung-Chang .
BMC GASTROENTEROLOGY, 2012, 12
[5]   RISK-FACTORS FOR HIP FRACTURE IN WHITE WOMEN [J].
CUMMINGS, SR ;
NEVITT, MC ;
BROWNER, WS ;
STONE, K ;
FOX, KM ;
ENSRUD, KE ;
CAULEY, JC ;
BLACK, D ;
VOGT, TM .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (12) :767-773
[6]   Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].
Downs, JR ;
Clearfield, M ;
Weis, S ;
Whitney, E ;
Shapiro, DR ;
Beere, PA ;
Langendorfer, A ;
Stein, EA ;
Kruyer, W ;
Gotto, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622
[7]   Oral statins and increased bone-mineral density in postmenopausal women [J].
Edwards, CJ ;
Hart, DJ ;
Spector, TD .
LANCET, 2000, 355 (9222) :2218-2219
[8]   Alendronate mechanism of action:: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro [J].
Fisher, JE ;
Rogers, MJ ;
Halasy, JM ;
Luckman, SP ;
Hughes, DE ;
Masarachia, PJ ;
Wesolowski, G ;
Russell, RGG ;
Rodan, GA ;
Reszka, AA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (01) :133-138
[9]  
Fujihara Y, 2017, J GEN FAM MED, V18, P237, DOI 10.1002/jgf2.56
[10]  
Gotoh Mituhiro, 2011, Fukushima J Med Sci, V57, P19